Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
Contributeurs/tricesBreville, Gautier; Lascano, Agustina Maria ; Roux-Lombard, Pascale; Vuilleumier, Nicolas; Lalive d'Epinay, Patrice
Publié dansNeurology: Neuroimmunology & Neuroinflammation, vol. 8, no. 5, e1031
Date de publication2021
Résumé
Citation (format ISO)
BREVILLE, Gautier et al. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP. In: Neurology: Neuroimmunology & Neuroinflammation, 2021, vol. 8, n° 5, p. e1031. doi: 10.1212/NXI.0000000000001031
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:155819
- DOI : 10.1212/NXI.0000000000001031
- PMID : 34140310
URL commercialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216426/
ISSN du journal2332-7812